abiraterone heaton 500mg potahovaná tableta
heaton k.s., praha array - 19572 abirateron-acetÁt - potahovaná tableta - 500mg - abirateron
abiraterone vipharm 500mg potahovaná tableta
vipharm s.a., ożarów mazowiecki array - 19572 abirateron-acetÁt - potahovaná tableta - 500mg - abirateron
bicaluplex 150mg potahovaná tableta
teva pharmaceuticals cr, s.r.o., praha array - 13723 bikalutamid - potahovaná tableta - 150mg - bikalutamid
bicaluplex 50mg potahovaná tableta
teva pharmaceuticals cr, s.r.o., praha array - 13723 bikalutamid - potahovaná tableta - 50mg - bikalutamid
binabic 150mg potahovaná tableta
vipharm s.a., ożarów mazowiecki array - 13723 bikalutamid - potahovaná tableta - 150mg - bikalutamid
androcur 50mg tableta
bayer ag, leverkusen array - 2141 cyproteron-acetÁt - tableta - 50mg - cyproteron
binabic 50mg potahovaná tableta
vipharm s.a., ożarów mazowiecki array - 13723 bikalutamid - potahovaná tableta - 50mg - bikalutamid
decapeptyl depot 3,75mg/ml prášek a rozpouštědlo pro injekční suspenzi s prodlouženým uvolňováním
ferring pharmaceuticals cz s.r.o., jesenice u prahy array - 10211 triptorelin-acetÁt - prášek a rozpouštědlo pro injekční suspenzi s prodlouženým uvolňováním - 3,75mg/ml - triptorelin
degarelix accord
accord healthcare s.l.u. - degarelix acetate - prostatetické novotvary - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
myodine 25 mg/ml injekční roztok
le vet beheer, b.v. - nandrolon - injekční roztok - estren deriváty - psi, kočky